SCHEMBL24812337

SCHEMBL24812337

CSC(=O)c1cccc(Oc2ccccc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.66
HDAC8 Q9BY41 1/20 0.58
ERCC5 P28715 1/20 0.54
FEN1 P39748 1/20 0.54
TNKS O95271 1/20 0.51
PARP15 Q460N3 1/20 0.51
PARP14 Q460N5 1/20 0.51
PARP10 Q53GL7 1/20 0.51
TNKS2 Q9H2K2 1/20 0.51
PARP2 Q9UGN5 1/20 0.51
NPC1 O15118 2/20 0.51
PGR P06401 2/20 0.51
TLR4 O00206 1/20 0.50
TLR2 O60603 1/20 0.50
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PKM P14618 1/20 0.49
PTGS1 P23219 1/20 0.49
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2350424 0.80 AKR1C3 (0.72) AKR1C3HDAC8ERCC5FEN1TNKS
M-Phenoxybenzoic Acid For Cis-Isomer SCHEMBL30445868 0.80 AKR1C3 (1.00) AKR1C3HDAC8ERCC5FEN1TNKS
SCHEMBL21887184 0.80 AKR1C3 (0.78) AKR1C3HDAC8ERCC5FEN1TNKS
M-Phenoxybenzoic Acid For Cis-Isomer SCHEMBL29522837 0.80 AKR1C3 (1.00) AKR1C3HDAC8ERCC5FEN1TNKS
SCHEMBL8897485 0.80 AKR1C3 (0.78) AKR1C3HDAC8ERCC5FEN1TNKS
M-Phenoxybenzoic Acid For Cis-Isomer SCHEMBL128732 0.80 AKR1C3 (1.00) AKR1C3HDAC8ERCC5FEN1TNKS
SCHEMBL4900017 0.78 AKR1C3 (0.75) AKR1C3HDAC8ERCC5FEN1TNKS
SCHEMBL4320685 0.78 AKR1C3 (0.96) AKR1C3HDAC8ERCC5FEN1TNKS
SCHEMBL11002454 0.78 AKR1C3 (0.75) AKR1C3HDAC8ERCC5FEN1TNKS
SCHEMBL11593624 0.78 AKR1C3 (0.75) AKR1C3HDAC8ERCC5FEN1TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022272106-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2022-12-29 WO disclosed